Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

GDC-0349

Catalog No. T6510Cas No. 1207360-89-1
Alias RG-7603

GDC-0349 (RG-7603) is a potent and selective ATP-competitive inhibitor of mTOR with Ki of 3.8 nM, 790-fold inhibitory effect against PI3Kα and other 266 kinases. Phase 1.

GDC-0349

GDC-0349

Purity: 98.98%
Catalog No. T6510Alias RG-7603Cas No. 1207360-89-1
GDC-0349 (RG-7603) is a potent and selective ATP-competitive inhibitor of mTOR with Ki of 3.8 nM, 790-fold inhibitory effect against PI3Kα and other 266 kinases. Phase 1.
Pack SizePriceAvailabilityQuantity
2 mg$33In Stock
5 mg$61In Stock
10 mg$109In Stock
25 mg$226In Stock
50 mg$340In Stock
100 mg$487In Stock
500 mgInquiryIn Stock
1 mL x 10 mM (in DMSO)$64In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "GDC-0349"

Select Batch
Purity:98.98%
ee:100%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
GDC-0349 (RG-7603) is a potent and selective ATP-competitive inhibitor of mTOR with Ki of 3.8 nM, 790-fold inhibitory effect against PI3Kα and other 266 kinases. Phase 1.
Targets&IC50
mTOR:3.8 nM(Ki)
In vitro
GDC-0349 has remarkable selectivity over 266 kinases, including all isoforms of PI3K. GDC-0349 inhibits downstream markers of mTOR, including phospho-4EBP1 and phospho-Akt(S473) in an in vivo PK/PD study in mouse, consistent with an inhibition of both mTORC1 and mTORC2 complexes. [1]
In vivo
GDC-0349 demonstrates pathway modulation and dose-dependent efficacy in mouse xenograft cancer models. When dosed orally once daily in athymic mice in a MCF7-neo/Her2 tumor xenograft model (PI3K mutation), GDC-0349 inhibits tumor growth in a dose-dependent manner. It is also efficacious in other xenograft models, including PC3 (PTEN null) and 786-O (VHL mutant). [1]
AliasRG-7603
Chemical Properties
Molecular Weight452.55
FormulaC24H32N6O3
Cas No.1207360-89-1
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
Ethanol: 6 mg/mL (13.25 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 84 mg/mL (185.6 mM)
Solution Preparation Table
Ethanol/DMSO
1mg5mg10mg50mg
1 mM2.2097 mL11.0485 mL22.0970 mL110.4850 mL
5 mM0.4419 mL2.2097 mL4.4194 mL22.0970 mL
10 mM0.2210 mL1.1049 mL2.2097 mL11.0485 mL
DMSO
1mg5mg10mg50mg
20 mM0.1105 mL0.5524 mL1.1049 mL5.5243 mL
50 mM0.0442 mL0.2210 mL0.4419 mL2.2097 mL
100 mM0.0221 mL0.1105 mL0.2210 mL1.1049 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy GDC-0349 | purchase GDC-0349 | GDC-0349 cost | order GDC-0349 | GDC-0349 chemical structure | GDC-0349 in vivo | GDC-0349 in vitro | GDC-0349 formula | GDC-0349 molecular weight